非典型脑膜瘤挽救治疗结局
该单中心回顾性研究纳入65例复发非典型脑膜瘤患者,中位影像随访4.0年,挽救治疗包括手术(21%)、手术联合放疗(25%)或单纯放疗(54%),2年局部无复发率分别为36%、59%和73%(P=0.01)。20%患者出现CTCAE≥3级毒性,39%患者经历≥3次复发。多因素logistic回归仅多灶性局部复发与进一步复发相关。
要点
- 复发非典型脑膜瘤挽救治疗后2年局部无复发率:单纯放疗73%、手术联合放疗59%、手术36%(P=0.01)。
- 20%患者发生CTCAE≥3级毒性,39%患者经历≥3次复发。
- 多因素分析仅多灶性局部复发与挽救治疗后进一步复发相关。
核心结论
- 复发非典型脑膜瘤在临床和病理上比原发非典型脑膜瘤更具侵袭性,挽救治疗获得持久局部控制的可能性更低。
研究设计与样本
- 单中心回顾性病历审查,纳入65例接受挽救治疗的非典型脑膜瘤患者,采用Kaplan-Meier法和Cox比例风险模型分析。
主要发现
- 65例复发非典型脑膜瘤患者中位影像随访4.0年(范围1.9-6.6年),共接受62次手术和114次放疗作为挽救治疗。
- 挽救方式为手术(21%)、手术联合放疗(25%)或单纯放疗(54%),对应的2年局部无复发率分别为36%、59%和73%(P=0.01)。
- 20%患者发生挽救治疗相关CTCAE≥3级毒性,39%患者经历≥3次复发。
- 首次和第二次挽救治疗后的中位无病生存间隔分别为2.9年和1.3年。
- 单因素Cox分析显示,既往次全切除、既往放疗、肿瘤直径>2.5 cm和多灶性局部复发与挽救治疗后复发相关;多因素logistic回归仅多灶性局部复发与进一步复发相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atypical menginomas demonstrate increased clinical aggressiveness characterized by recurrence and diminished survival. The optimal management of atypical meningioma in the recurrent setting is especially not well defined. To characterize outcomes following salvage treatment of recurrent atypical meningioma and to identify risk factors for further recurrence. Retrospective chart review was performed on 65 patients who underwent salvage treatment of atypical meningioma at a single institution. Data were analyzed using the Kaplan-Meier method and Cox proportional hazards modeling. Sixty-five patients with recurrent atypical meningioma and median imaging follow-up of 4.0 years (range 1.9-6.6 years) underwent 62 surgeries and 114 radiation treatments (RT) for salvage therapy. Salvage modality was surgery (21%), surgery/RT (25%), or RT alone (54%), associated with 2 year local freedom from recurrence (LFFR) of 36, 59, and 73%, respectively (P = 0.01). Twenty percent of patients experienced CTCAE grade ≥ 3 toxicity with salvage therapy. Thirty-nine percent of patients experienced ≥ 3 recurrences. The median disease-free survival intervals after first and second salvage treatments were 2.9 and 1.3 years, respectively. On univariate Cox analysis, prior subtotal resection, prior RT, tumor diameter > 2.5 cm, and multifocal local recurrence were associated with recurrence after salvage therapy. On multivariate logistic regression, only multifocal local recurrence was associated with further recurrence. Recurrent atypical meningioma is clinically and pathologically more aggressive than primary atypical meningioma, and the likelihood of durable local control with salvage therapy is lower. Future efforts should identify patients at risk of recurrence, and aggressive upfront treatment should be employed.
引用
- Chen WC, Hara J, Magill ST, et al. Salvage therapy outcomes for atypical meningioma. J Neurooncol. 2018. PMID: 29480505. doi:10.1007/s11060-018-2813-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。